Literature DB >> 10074173

Transcriptional repression of human hepatitis B virus genes by a bZIP family member, E4BP4.

C K Lai1, L P Ting.   

Abstract

Box alpha is an essential element of both the upstream regulatory sequence of the core promoter and the second enhancer, which positively regulate the transcription of human hepatitis B virus (HBV) genes. In this paper, we describe the cloning and characterization of a box alpha binding protein, E4BP4. E4BP4 is a bZIP type of transcription factor. Overexpression of E4BP4 represses the stimulating activity of box alpha in the upstream regulatory sequence of the core promoter and the second enhancer in differentiated human hepatoma cell lines. E4BP4 can also suppress the transcription of HBV genes and the production of HBV virions in a transient-transfection system that mimics the viral infection in vivo. Expression of an E4BP4 antisense transcript can, instead, elevate the transcription of the core promoter. A low abundance of E4BP4 protein and mRNA in differentiated human hepatoma cell lines is detected, and E4BP4 is not a major component of box alpha binding proteins in untransfected differentiated human hepatoma cell lines. C/EBPalpha and C/EBPbeta, in contrast, are major components of the box alpha binding activity present in nuclear extracts. E4BP4 has a stronger binding affinity towards box alpha than the endogenous box alpha binding activity present in nuclear extracts. Structure and function analysis of E4BP4 reveals that DNA binding activity is sufficient to confer the negative regulatory function of E4BP4. These results indicate that binding site occlusion is the mechanism whereby E4BP4 suppresses transcription in HBV.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074173      PMCID: PMC104083     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Stress-induced binding of the transcriptional factor CHOP to a novel DNA control element.

Authors:  M Ubeda; X Z Wang; H Zinszner; I Wu; J F Habener; D Ron
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  Protein-protein interaction between the transcriptional repressor E4BP4 and the TBP-binding protein Dr1.

Authors:  I G Cowell; H C Hurst
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

Review 3.  Transcriptional repression in development.

Authors:  S Gray; M Levine
Journal:  Curr Opin Cell Biol       Date:  1996-06       Impact factor: 8.382

Review 4.  Active repression mechanisms of eukaryotic transcription repressors.

Authors:  W Hanna-Rose; U Hansen
Journal:  Trends Genet       Date:  1996-06       Impact factor: 11.639

5.  A novel C/EBP beta-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region.

Authors:  T Bauknecht; R H See; Y Shi
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  Competition for a unique response element mediates retinoic acid inhibition of vitamin D3-stimulated transcription.

Authors:  X Cao; S L Teitelbaum; H J Zhu; L Zhang; X Feng; F P Ross
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

7.  Physical and functional association between GADD153 and CCAAT/enhancer-binding protein beta during cellular stress.

Authors:  T W Fawcett; H B Eastman; J L Martindale; N J Holbrook
Journal:  J Biol Chem       Date:  1996-06-14       Impact factor: 5.157

8.  Characterization of a functional hepatocyte nuclear factor 3 binding site in the hepatitis B virus nucleocapsid promoter.

Authors:  J L Johnson; A K Raney; A McLachlan
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

9.  Characterization of human E4BP4, a phosphorylated bZIP factor.

Authors:  W J Chen; K S Lewis; G Chandra; J P Cogswell; S W Stinnett; S H Kadwell; J G Gray
Journal:  Biochim Biophys Acta       Date:  1995-12-27

10.  Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6.

Authors:  P L Chen; D J Riley; S Chen-Kiang; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

View more
  8 in total

1.  E4BP4 is a cardiac survival factor and essential for embryonic heart development.

Authors:  Yi-Jiun Weng; Dennis Jine-Yuan Hsieh; Wei-Wen Kuo; Tung-Yuan Lai; Hsi-Hsien Hsu; Chang-Hai Tsai; Fuu-Jen Tsai; Ding-Yu Lin; James A Lin; Chih-Yang Huang; Kwong-Chung Tung
Journal:  Mol Cell Biochem       Date:  2010-02-26       Impact factor: 3.396

2.  Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II.

Authors:  H Ishida; K Ueda; K Ohkawa; Y Kanazawa; A Hosui; F Nakanishi; E Mita; A Kasahara; Y Sasaki; M Hori; N Hayashi
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 3.  The transcriptional regulator NFIL3 controls IgE production.

Authors:  Paul B Rothman
Journal:  Trans Am Clin Climatol Assoc       Date:  2010

4.  Mechanisms of inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by hepatocyte nuclear factor 3beta.

Authors:  Hong Tang; Alan McLachlan
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  IL-4-induced transcription factor NFIL3/E4BP4 controls IgE class switching.

Authors:  Masaki Kashiwada; Deborah M Levy; Lisa McKeag; Keri Murray; Andreas J Schröder; Stephen M Canfield; Geri Traver; Paul B Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

6.  Identification of bZIP interaction partners of viral proteins HBZ, MEQ, BZLF1, and K-bZIP using coiled-coil arrays.

Authors:  Aaron W Reinke; Gevorg Grigoryan; Amy E Keating
Journal:  Biochemistry       Date:  2010-03-09       Impact factor: 3.162

7.  A novel E4BP4 element drives circadian expression of mPeriod2.

Authors:  Tomoya Ohno; Yoshiaki Onishi; Norio Ishida
Journal:  Nucleic Acids Res       Date:  2006-12-19       Impact factor: 16.971

8.  New Frontiers for the NFIL3 bZIP Transcription Factor in Cancer, Metabolism and Beyond.

Authors:  Megan Keniry; Robert K Dearth; Michael Persans; Ramon Parsons
Journal:  Discoveries (Craiova)       Date:  2014 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.